Optic Neuritis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Optic neuritis is an inflammatory
condition of the optic nerve characterized by a sudden onset of unilateral visual
loss, usually affecting young females. Optic neuritis is an inflammatory
condition affecting the optic nerve, usually affecting young adults, especially
females, between 18 and 45 years of age. Most cases are idiopathic in nature
and associated with demyelinating lesions, of which multiple sclerosis (MS) is
the most common cause. Other less common etiologies include infectious and
para-infectious causes and inflammatory and para vaccination immunological
responses. Typical optic neuritis in adults usually presents as acute monocular
loss of vision progressing over several hours to days, often associated with
ocular pain that worsens on eye movement. The diagnosis of optic neuritis is a
clinical one, made in a patient of appropriate age with the clinical features
mentioned above. Although no investigations are necessary for confirming the
diagnosis, investigations are needed to assess the risk of developing MS and to
rule out other disorders.
- Optic neuritis is reported to have an
incidence of 1-5 cases per 100,000 population in the USA.
Thelansis’s “Optic Neuritis Market
Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Optic
Neuritis treatment modalities options for eight major markets (USA, Germany,
France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Optic Neuritis across 8 MM market from the centre of Excellence/ Public/
Private hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Optic Neuritis Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment